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tlistamine release by propanidid and thiopentone was demonstrated with the use of a highly sensitive and 
specific method for determining histamine in human plasma. 5 min after i.v. administration of propanidid and 3 rain 
after thiopentone, the plasma histamine level was increased by 350 and 4205~ respectively. In whole blood, hista- 
mine release could be demonstrated only when the basophil content remained constant. This was the case in about 
50% of test persons after injection of propanidid, but not after administration of thiopentone where the basophil 
content decreased in all probands by about 35%. The increase of the histamine concentration i  plasma was 3 ng/ml 
and in whole blood, 24 ng/ml, ttalfmaximum gastric acid secretion was elicited by injection of propanidid and 
thiopentone. It was increased by very rapid application of propanidid and diminished by premedication with 
atropine by about 30%. The changes in plasma histamine and gastric secretion were parallel over 30 rain, whereas 
tachycardia and peripheral arterial hypotension lasted for only 3 4 min. 
During i.v. infusion of histamine a correlation could be shown between the doses infused, (15-90 ng/kg)/min, 
and the elevation of the plasma histamine concentration. 3 ng/ml plasma were measured at a dose of 145 ng/kg)/min, 
which induced a half-maximmn gaslric secretion, but was without effect on blood pressure and heart rate. It is 
concluded that only the increase of plasma histamine concentration, ot that of whole blood, represented the 
release of free, pharmacologically active histamine. In normal test persons, histamine release by propanidid and 
thiopentone is without significant clinical consequences, but it is important in anaphylactoid ncidents occurring 
during anesthesia with these substances. 
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1. INTRODUCTION 
Histamine release by drugs used before and during 
anesthet ic administ rat ion in man and animals has 
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Pathological Biochemistry, Surgery Clinic of University 
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been proven by numerous  authors,  since its first ob- 
servation by Alam et al. (1939)  in the skeletal muscle 
of  dogs (for reviews see Paton, 1956, 1957, 1959; 
Murphy,  1962; Rotschi ld,  1966; Lorenz and Werle, 
1971). Somet imes direct methods  have been used, 
when histamine itself was measured in body fluids or 
in tissues. More often,  however,  indirect methods  
have been employed when clinical symptoms and 
changes of  pharmacological ly measurable parameters,  
such as gastric secretion, decrease in peripheral arte- 
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rial blood pressure, tachycardia nd increase in bron- 
chial resistance, were concluded to be a result of his- 
tamine release. These symptoms and measurable r ac- 
tions are, however, specific for histamine only in a 
limited sense. 
Direct proof of histamine release by drugs adminis- 
tered before and during anesthesia is extremely diffi- 
cult to obtain in humans, despite availability of sim- 
ple specific assay methods for determination of hista- 
mine in whole blood, because an increase of free, 
pharmacologically active plasma histamine is masked 
by the nearly 100-fold higher concentrations of hista- 
mine stored in the blood within the basophil granu- 
locytes (Code, 1952; Lorenz and Werle, 1971). 
The histamine content of human plasma is so low, 
that its determination has in the past been especially 
difficult (Adam et al., 1957; Graham et al.,1968). 
However, with an improved, highly sensitive and spe- 
cific method for plasma histamine determination 
(Lorenz et al., 1970a; Lorenz et al., 1972) it has been 
possible, to show histamine release in man by 2 anes- 
thetic drugs often used in European clinics: propa- 
nidid and thiopentone. Recent information of ana- 
phylactoid incidents during anesthesia with both sub- 
stances led us to this investigation. To demonstrate 
that the increased concentration of plasma histamine 
was actually free, pharmacologically active histamine, 
gastric acid secretion, heart or pulse rate and periph- 
eral arterial blood pressure were also measured. To 
determine whether histamine release in man can be 
demonstrated by histamine assay of whole blood, the 
histamine concentration and the density of basophilic 
granulocytes in whole blood, in which histamine in 
humans may be localized almost exclusively, were 
also measured. 
2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Drugs 
Propanidid (Bayer, Leverkusen): a colloidal solu- 
tion consisting of propanidid (3-methoxy-4-(N,N-di- 
ethylcarbamoylmethoxy)-phenylacetic acid-n-propyl 
ester), Micellophor (20%), NaC1 and phosphate salts, 
as well as water, prepared according to instructions of 
the company (Wirth and Hofmeister, 1965; Scholtan 
and Lie, 1966). 
Micellophor ® (Bayer Leverkusen): a colloidal solu- 
tion consisting of 20% Micellophor = ORPE (oleum 
ricini polyoxyethylate Elberfeld), NaCI and phos- 
phate salts, as well as water, as stated by the manufac- 
turer. Micellophor contains the hydrophobic onrpo- 
nents of Cremophor EL ® (BASF, Ludwigshafen), 
which was used in diluted form until 1967 as a sol- 
vent for propanidid (Doenicke et al., 1968), and con- 
sists of ricinoleic acid, polyglycol esters and glycerol, 
polyglycol ethers. 
Thiopentone (Penthotal ®, Abbott, lngelheim). 
Atropinum sulfuricum (from University's phar- 
macy). 
Antazoline (Antistin @, Ciba, Basel). 
2.1.2. Reagents 
Histamine dihydrochloride puriss. (Fluka, Buchs), 
o-phtaldialdehyde puriss, p.a. (Fluka, Buchs) (recrys- 
tallized from petrol ether p.a., b.p. 40 60°), metha- 
nol, n-heptane, inorganic acids and bases as Uvasol @ 
(Merck, Darmstadt), n-butanol (for chromatography, 
Riedel de Haen, Seelze near Hannover), Dowex 
50W-X8, H*, mesh 200 400 (Serva, Heidelberg). 
Unless otherwise stated, all substances were dissolved 
in twice distilled water. 
Heparin for biochemical research (180 l.U./mg)* 
(Hoffmann-La Roche, Grenzach)), 0.1 N NaOH for 
titration of the gastric juice (Titrisol @, Merck, Darm- 
stadt), TiJrk's solution for leucocyte counts (acetic 
acid-gentian violet), May-Grunwald's solution 
(eosin-methylene blue) and Giemsa stain (azur- 
eosin methylene blue) (Merck, Darmstadt). 
2.2. Test persons 
The investigations were carried out on 143 volun- 
teers. The test persons had healthy case histories and 
in particular were devoid of allergic reactions, gastric 
diseases or complaints, and had normal pulse rate and 
blood pressure in sitting and prone positions, normal 
leucocyte counts and/or normal differential blood pic- 
ture. The test persons consisted of 140male and 
2 female students and anesthetists between the ages 
of 22 and 31 years, weighing between 54 and 100 kg; 
* We thank Professor Dr. H. Gastpar, Munich, for supplying 
this substance. 
one test person (A. Doenicke) was himself one of the 
Investigators in this paper. 
3.3. Seqrrevr~e arid urrungemettr 0,f ittvrs~igaliott 
The tests were conducted f‘tu11 7 a111 to 9 a111 in a 
quiet well-lit room. The anaesthetic was administered 
during spontaneous respiration. The test persons. on 
whom all investigative parameters were measured 
simultaneously. were handled in the following se- 
quence and arrangement (fig. 1 ). 
Blood Pressure 
Venous Blood. 
e Blood Histamw 
Fig. I. Scheme of the arrangement of investigations in the test 
persons. I.or explanations we test under Matemls and 
hlethods. 
To begin with. a nasogastral tube with X-ray con- 
trast strips (Levin No. I?- 14) was introduced into the 
stomach. the position of which was radiologically 
controlled and. if necessary. corrected. After the tube 
was fixed on his nose, the test person laid down on a 
sofa with the upper body slightly raised. Leads for 
the ECG were attached to the extremities and a 
sphygmomanometer (Riva- Rocci) to measure blood 
pressure was fastened to the right upper arm. Then. in 
the right and left under-arms, polyethylene cannulae 
(Braunule@. Braun. Melsungen) were inserted into 
superficial veins, the right one being used for the in- 
jection of the anesthetic. solvent and other drugs, the 
left one being used for withdrawing blood for hista- 
mine assay in plasma and whole blood, as well as for 
leucocyte counts and blood smears. Capillary blood 
from the finger tips of the left hand was also used to 
determine leucocyte counts and the differential blood 
pictures. 
If 1 or 2 of the parameters were not simultaneous- 
ly measured, then the sequence of those still to be 
investigated remained. as stated above. To carry out 
this program, a very well-practiced team of at least 
5 persons, including 7 anesthetists. was absolutely 
necessary. 
When in any one of the investigations. ;I solvent 
and agent, or an agent at various conditions, were 
employed on one and the s;lnle test person, then the 
sequence of application of both solutions was alter- 
nated. Thus. when in one person Micellophor’“, WiIS 
used first and then Propanidid. in the next test person 
Propanidid was used first and then the solvent. The 
time lapse between the first and second investigation 
was always 2- 4 weeks. 
The order as described above was also adhered to 
in studies with histamine infusion. Gastric acid secre- 
tion was not determined since the dosc~- effect rela- 
tionship between histamine infusion and gastric acid 
secretion in humans is known from the literature 
(Hanson and Ivy. 1948: Adam et al., 1954; Lawrie et 
al., 1964; Lorenz and Pflcger, 1968). 
The histamine solution was prepared using a steril- 
iLed stock solution from the University’s pharmacy. 
diluting it with physiological saline. and then drawing 
it up into a SO-ml polyethylene syringe. The hista- 
mine concentration of the fluid within the syringe 
was determined after the investigation by tluoromct- 
ric assay. There was no loss of histamine caused b>, an 
adsorption onto the syringe surface. 
I.v. infusions were given into the right arm using 
the infusion apparatus Unita II (Braun, Melsungen). 
while blood was withdrawn from a cuhital vein of the 
left arm, as in the other investigations. At the begin- 
ning, 0.9% NaCl solution was infused, followed by 
the application of histamine from a separate syringe 
after which physiological saline was again infused. 
To avoid any side effects from infusion of the 
highest dose (headache, flush, etc.). the antihistaminic 
drug antazoline, 2 mg/kg, was injected i.v. immedi- 
ately prior to infusion. 
2.4. Deterntimbon of’the various parmerers 
2.4.1. Histamine assay in whole blood and plasma 
From the left underarm, 5.0 ml of blood were 
withdrawn with a polyethylene syringe 15 min before 
and immediately before, injection of the anesthetic or 
solvent. as well as at intervals of 3, 6. 10. 30 and 
30 min after the i.v. application. The blood samples 
were put immediately into centrifuge tubes contain- 
ing 5.0 ml 1 N HC104 and centrifuged for 5 min at 
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1800g. 4.0 ml of the supernatant were stored for 
several days in a freezer at -20°C and used later for 
histamine assay according to Lorenz et al, (1970a, 
197 la) (Dowex method). 
lnnnediately after the withdrawal of blood sanr- 
pies for whole blood histamine determination, 
19.5 ml of blood were withdrawn with a polyethyl- 
ene syringe containing 2 mg heparin dissolved in 
0.5 ml of 0.9% NaC1 solution and centrifuged imme- 
diately for 30min at 1000g and l-2°C. 6.0ml of 
plasma were mixed with 2 ml of 2 N HC104 and 
centrifuged, for 10 min at 1800g. The whole super- 
natant was filtered through a filter paper and was 
either used immediately for histamine assay or stored 
in the freezer at -20°C, and histamine assayed several 
days later. Histamine was determined on a Zeiss spec- 
trofluorometer ZFM 4 at a temperature of 21-+0.5°C 
according to Lorenz et al. (1970a, 1972) (combined 
method). 
Two types of blanks were used, in one 3 N HCI 
was added to the mixture before the o-phtaldialde- 
hyde solution (Shore et al., 1959, reversed blanks), in 
the other the plasma was substituted by fresh twice 
distilled water (histamine-free) and carried along 
throughout the procedure (reagent blanks). The high 
sensitivity of our method was partly due to strict 
control of the reagent blanks which should not be 
more than l(F/o higher than the reversed blanks (on 
the contrary see Van Redlich and Glick, 1965). On 
the other hand, the low concentration of o-phtaldial- 
dehyde used in our method, 0.05%, w/v, diminished 
both blanks considerably and thus increased the sen- 
sitivity of our assay. 
2.4.2. Determination of gastric acid secretion (Lorenz 
et al., 1969; Lorenz, 1971). 
After complete mptying of the stomach with a 
manually operated syringe, the nasogastral tube posi- 
tion was again tested by instillation of 20 ml of 0.9% 
NaCI solution (37°C) and reaspiration. Then basal 
secretion was collected by suction at intervals of 
2 rain over a period of 30 min. When atropine had to 
be used, a dose of 0.01 mg/kg was administered i.v. 
15 rain after the beginning of the collection. At the 
end of the 30 min, the anesthetic was injected and 
the gastric juice withdrawn by suction every rain and 
collected in portions corresponding to the blood 
withdrawal, i.e., in 2 3-rain portions, 1 4-min portion 
and 2 10-rain portions. The volume of gastric juice 
was measured and the acid output determined for 
each portion by titration with 0.1 N NaOH upto 
pH 7.0 using a glass electrode. The acid output was 
given in nwal HCl/min (Lorenz et at., 1969). 
2.4.3. Determination of heart rate and blood pressure 
The heart rate (beats/rain) was determined from 
the average period length in lead I1 of the standard 
ECG (Heinecker, 1970). The arterial blood pressure 
(in mm Hg) was determined by indirect, sphygmano- 
metric measurement (Riva-Rocci) according to the 
method of Burton (1965). Because the test persons 
were all young people (very little or no arteriosclero- 
sis!), the blood pressure values obtained by the in- 
direct method would have been similar to those ob- 
tained by a direct method. Indeed, the blood pressure 
values measured by indirect methods during anesthe- 
sia with propanidid agreed with those obtained by 
direct methods (Henschel and Buhr, 1965; Avrucki 
and Zinovjev, 1969; Soga and Beer, 1971). 
2.4.4. Determination of basophil granulocyte content 
in peripheral venous and capillary blood 
At the same time as the blood was withdrawn for 
histamine assay, 2 blood smears and I leucocyte 
count were made with venous and capillary blood. 
The leucocyte count was performed according to Von 
Mtiller et al. (1962), while the blood differential was 
determined according to Pappenheim, whereby 
1000 cells from each sample were counted. The con- 
tent of basophils in venous and capillary blood was 
determined according to Hamerston et al. (1956) 
(number of leucocytes/ram 3 and per cent of baso- 
phils in the blood smear). As the results of Moore and 
James (153) and Hamerston et al. (1956) have shown, 
the values from such an indirect method agree with 
those front a direct method. The content of basophils 
in the blood is given as the number of cells/ram 3. 
3. RESULTS 
3.1. Plasma histamine levels during inJusion of  hista- 
mine and its correlation to heart rate attd blood pres- 
sure 
With the highly sensitive histamine assay used in 
this study, an increase of plasma histanrine concentra- 
tion was measured after infusion of relatively low doses 
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Fig.2. Plasma histamine concentration, blood pressure and 
heart rate after intravenous infusion of increasing doses of 
histamine. Mean value + S.E.M., 3 probands were tested. For 
further conditions see Materials and Methods. 
of histamine, (18-90  ng/kg)/min. Furthermore,  
there was a relationship between the doses of  hista- 
mine infused and the elevation of plasma histamine 
level (fig.2). 
Doses of histamine up to (45 ng/kg)/min did not 
produce complaints or clinical symptoms in any of  
the 3 test persons. No effects on blood pressure or 
heart rate were observed, both relatively sensitive in- 
dicators of  histamine release. Clinical reactions (a 
slight tachycardia nd in one case only, also a slight 
headache) were observed after infusion of 
(90 ng/kgl/min, despite antihistamine medication. 
3.2. Histamine release b.v propanidid and thiopentone 
3.2.1. Concentrat ions of plasma histamine after i.v. 
in jet  tion 
After i.v. administrat ion of propanidid,  in doses 
commonly  used for anesthesia in man, the plasma 
histamine levels increased significantly to about 350% 
of  the norm (table 1): the highest value was fl)und 
5 rain after injection. The histamine concentrat ion re- 
mained at an increased level even though anesthesia 
by propanidid had long since been ended. At least 
30 rain after the end of injection was required for 
histamine concentrat ion to approximate to the initial 
levels (table 1). The i.v. administration of atropine 
did not significantly affect the concentrat ion of plas- 
ma histamine, although this agent has been proven to 
Table l 
Plasma histamine concentrations in man before and after the i.v. injection of propanidid, Micellophor ® and thiopentone. Mean 
values ± S.D. With propanidid, 7 mg/kg, i.v., injection time 20 sec, and Micellophor ®0.15 ml/kg, i.v., injection time 20 sec, 12 
male test persons were tested, with thiopentone, 5 mg/kg, i.v., injection time 20 sec, 8 male probands were studied. Statistical sig- 
nificance was calculated between the values at zero time and those at several times after the injection. For further conditions see 
Materials and Methods. 
Time after Propanidid Micellophor ® Thiopentone 
injection 
(min) Histamine Signifi- liistamine Signifi- Histamine Signifi- 
content (ng/ml) cance content (ng/ml) cance content (ng/ml) cance 
0 0.85 + 0.33 - 0.86 -+ 0.36 - 0.80 +_ 0.32 
1 2.10 + 1.30 p < 0.005 1.03 + 0.63 p < 0.4 - 
3 - 0.88 + 0.50 4.2 _+ 3.1 p < 0.01 
5 3.80 + 2.10 p < 0.005 0.92 +- 0.58 - -. 
6 - - 2.9 _+ 1.3 p < 0.001 
10 2.40 + 1.70 p < 0.01 0.94 ± 0.76 - 2.0 + 0.9 p < 0.005 
20 1.50 _+ 0.55 p < 0.005 0.88 + 0.69 1.6 -+ 0.64 p < 0.001 
30 1.10 +- 0.52 p < 0.2 0.89 +_ 0.50 1.0 + 0.48 p < 0.4 
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be a histamine liberator in humans, dogs and cats 
(Schachter, 1952; Rotschild, 1966). 
For a long time, it has been assumed that the sol- 
vent of propanidid, Cremophor ®, or presently Micel- 
lophor ® released histamine ira humans since they 
liberate histamine in dogs and cats (Lorenz et al., 
1971b). In this study, the test persons who were 
treated with propanidid also received Cremophor ® 
and Micetlophor ® alone. The increase of plasma hista- 
mine concentration, about 20%, was not statistically 
significant (table 1). Thus, it can be concluded that 
propanidid (anesthetic drug plus solvent), and not 
Cremophor ® or Micellophor ®, releases histamine in 
hul ] lans.  
Thiopentone, ira anaesthetic doses, also elevated 
plasma histamine concentration (table 1). The degree 
of elevation approximated that obtained after ad- 
ministration of propanidid; also the concentration of 
plasma histamine fell at approximately the same rate 
as after propanidid. The solvent used for thiopentone, 
0.9% NaC1 solution did not lead to any increase of 
plasma histamine levels even when injected rapidly 
(see also fig.2). 
3.2.2. Histamine concentrations and basophil con- 
tents in whole blood after injection of propanidid, 
Micellophor ® and thiopentone 
After i.v. injection of propanidid, the histamine 
concentrations and basophil contents of whole blood 
were not uniformly changed (fig.3). 
(a) In those cases where the basophil content re- 
mained constant, the histamine concentration in- 
creased significantly. However, this increase, approxi- 
mately 30%, did not agree with the increase of plasma 
histamine concentrations previously obtained, which 
was smaller than the 24 ng/ml observed in whole 
blood. It must therefore be assumed that histamine 
was briefly increased in compartments of the blood 
other than plasma (see discussion); the level of hista- 
mine in whole blood was already decreased after 
30 min. 
(b) In those test persons in which whole-blood 
histamine concentration was not significantly 
changed, the number of basophils decreased signifi- 
cantly (fig.3). This could have been due to sequestra- 
tion or partly also to degranulation of basophils. 
Ideally histamine assay and basophil count should be 
made on the same blood sample, because there was a 
~ ropanidid ,,, 7~,k~) 
Basophils 
Gruup]  . . . .  
Group~ - -  
°oooeo- 2 
tration 
6 g g lb 20 3b ~ 
Fig.3. Histamine concentration and basophil content in 
human whole blood: two kinds of reaction to propanidid. 
Mean values _+ S.E.M. 29 male probands were tested with 
propanidid, 7mg/kg, i.v., injection time 20 sec. They were 
divided into 2 groups which reacted to the anesthetic in a 
different manner: (1) 13 probands, who showed no more 
than ± 10% difference in their basophil content in blood at 
any time investigated after the injection of propanidid 
(o - - -o ) .  (2) 16 probands, who showed more than -+ 10% 
change of their basophil content in blood (o-----o). The 
values at zero time were obtained from blood samples with- 
drawn immediately before the injection of propanidid. Statis- 
tical significance according to table 1. Statistical significance: 
(o - - -o )  no significance; o - -o ,  0/3 p<O.02, 0/6 p<0.05, 
0/10 p<0.1; (o- e) 0/3 p<0.05, 0/6 p<O.1, 0/10p<0.05, 
0/20 p<0.02, 0/30 p<0.1; (o o) no significance. For 
further conditions see Materials and Methods. 
large difference in the basophil content of venous and 
capillary blood; and no correlation between these 
values could be found (r = 0.37, p<0.4, n = 10). 
The histamine concentration and the basophil con- 
tent in whole blood remained unchanged after ad- 
ministering Cremophor ® and Micellophor ®. After in- 
jection of thiopentone, there was a decrease of the 
basophil content in practically all cases (fig.4). The 
histamine concentration of whole blood remained un- 
changed, in accord with one of the test groups receiv- 
ing propanidid (see fig.3). 
3.2.3. Gastric acid secretion after i.v. administration 
of propanidid, Micellophor ® and thiopentone 
Rapid injection of propanidid resulted in approxi- 
mately halfmaximal gastric acid secretion (table 2). 
The increased acid output parallel the increased plas- 
ma histamine concentration (fig.5); basal secretion 
was reached 30 min after injection. Micellophor @ did 
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l:ig.4. Itistamine concentration and basophil content in 
human whole blood after injection of thiopentone. Mean 
values +- S.EM. 22 male probands were tested with thiopen- 
tone, 5 mg/kg, i.v., injection time 20 sec. Atropine, 
0.01 mg/kg, i.v., was given as premedication 10 rain before 
thiopentone. Zero time is defined as in fig.3. Statistical sig- 
nificance according to table 1 (o----o), 0/3 p<0. l, 0/6 
p<0.02, 0/10 p<0.05, 0/20 p<0.2; (o e), no significance. 
[:or turther conditions see Materials and Methods. 
not significantly increase gastric secretion (table 2). 
After an extremely rapid injection of propanidid 
(as used often in the past and referred to as 'one-shot 
injection'), gastric acid secretion was much more 
profuse than after a slower injection (table 2). Proba- 
bly, slow injection of the drug resulted in less hista- 
mine being released, thus characterizing propanidid as 
a histamine liberator (Paton, 1956). This is somewhat 
surprising since propanidid is a neutral substance, 
whereas all other histamine liberators are basic com- 
pounds. It is furthermore remarkable that with the 
very rapid injection the highest rate of gastric acid 
secretion was reached not less than 10 rain after injec- 
tion of the anesthetic(table 2).
The effect of histamine on gastric acid secretion is 
usually reduced, but not completely blocked, by atro- 
pine (Ivy and Bachrach, 1966). When propanidid was 
administered 10 min after injection of atropine, gas- 
tric secretion was reduced approximately 31Y} (ta- 
ble 2). Therefore the increase of histamine in human 
plasma after injection of propanidid represents an in- 
crease of free, pharmacologically active histamine. 
Injection of thiopentone also stimulated gastric 
acid secretion in a similar manner to propanidid (ta- 
ble 3); for safety purposes, thiopentone was not ad- 
Blood ,2~ 
Pressure 
i mmH~ ) ~oo 
80 
Blood 7o 
Histamine Bo 
[ nglml } 
50 
eo  
Basop~ls 
[ ce l l s l~31 60 
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Acid o~ 
Output ms 
[ mval lmm ]01 
0O5 
O0 
Plasma a 1 
Histamine 2Ol 
[ , -~t  l , o I~  / 
, I - -  06 6 
, Tr'rTi lTrti 
. . . . .  . / ,}  
\ 
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5 *0 ~5 20 ~ 
Time t ~,0 ] 
Fig.5. Histamine concentration i whole blood and plasma, 
basophils, gastric acid secretion, blood pressure and heart rate 
after i.v. injection of propanidid. Mean values + S.E.M., 
5 probands were tested after injection of propanidid, 
7 mg/kg, i.v., injection time 20 sec. In each test person all 
parameters were studied simultaneously,  leart rate e--- o, 
blood pressure . - -e .  Blood pressure is given as systolic- 
diastolic pressure. [:or fu['thcr conditions ec Materials and 
Methods. 
ministered withoLtt atropine premeditation, l.v. injec- 
tion of 10 ml physiological saline, the solvent of 
thiopentone, did not stimulate gastric acid secretion. 
3.2.4. Heart rate and blood pressure after injection of 
propanidid, Micellophor ® and thiopentone 
The heart rate was increased uring the first 5 min 
after propanidid injection (fig.5). Systolic and diastol- 
ic blood pressure were significantly decreased uring 
the first 2 min only that is, before the maximum in- 
crease in plasma histamine concentration (fig.5). 
Therefore, it is improbable that the initial tachycardia 
and the acute peripheral arterial hypotension are re- 
lated to the release of histamine into the plasma, In 
contrast, stimulation of gastric acid secretion and de- 
crease of basophils in the blood paralleled the in- 
crease of plasma histamine concentration (fig.5). The 
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Table 2 
Gastric acid secretion in man after injection of Micellophor ® and propanidid at various conditions. Mean values ± S.D. 
Propanidid, 7 mg/kg, i.v., injection time 20 sec, if not otherwise stated. Micellophor ®, 0.15 ml/kg, i.v., injection time 20 sec. 
Atropine, 0.01 mg/kg, i.v., l0 rain before propanidid. Propanidid, slow means, an injection time of 40--50 sec: propanidid, rapid 
means, an injection time of 5 -7  sec. n = nmnber of male probands tested, in each series of experiments he sanle test persons were 
investigated. The basal secretion before the injection of atropine (last column) was 0.016 _+ 0.019 mval/min. Statistical signifi- 
cance was calculated as in table 1, the p-values are added in parentheses. For further conditions ee Materials and Methods. 
Time after Gastric acid output 0rival/rain) 
injection 
(min) Propanidid Micellophor ® Propanidid Propanidid Propanidid Propanidid 
(slow) (rapid) + atropine 
n = 9 n = 9 n = 11 n = 11 n = 9 n = 9 
0 0.03 ± 0.04 0.04 _+ 0.05 0.02 a 0.02 0.02 ± 0.02 0.02 ± 0.01 0.01 ± 0.01 
3 0.28 -+ 0.28 0.09 ± 0.12 0.13 ± 0.12 0.14 ± 0.12 0.32 -+ 0.29 0.15 ± 0.16 
(p < 0.02) (p < 0.3) (p < 0.005) Ip < 0.005) (p < 0.011 (p < 0.025/ 
6 0.25 +_ 0.21 0.09 ± 0.10 0.09 ± 0.11 0.18 ± 0.23 0.26 ± 0.21 0.20 _+ 0.23 
(p < 0.011 (p < 0.3) (p < 0.05) (p < 0.05) (p < 0.005) (p < 0.025) 
10 0.20 + 0.17 0.08 +_ 0.08 0.10 ± 0.13 0.25 ± 0.24 0.14 ± 0.10 0.11 + 0.13 
(p < 0.02) (p < 0.3) (p < 0.11 (p < 0.0051 (p < 0.005) (p < 0.05) 
20 0.10 + 0.09 0.07 ± 0.08 0.07 ~+ 0.11 0.12 ± 0.11 0.09 _+ 0.10 0.10 +_ 0.11 
(p < 0.11 ( - )  (p < 0.1t qr~ < 0.02) (p < 0.05) {.p < 0.05) 
30 0.05 _+ 0.07 0.03 ± 0.04 0.03 ± 0.03 0.07 _+ 0.09 0.03 ± 0.(i14 0.05 _+ 0.06 
( - i  ( ) t ) ~-) ( ) (p<0.051 
Table 3 
Gastric acid secretion in man after injection of thiopentone. 
Mean values -+ S.D. Thiopentone, 5 mg/kg, i.v., injection 
20 sec. Atropine, 0.01 mg/kg, i.v., 10 rain before thio- 
pentone. Basal secretion before atropine 0.021 + 0.015 (reval/ 
rain). 13 male probands were tested. Statistical significance 
was calculated as in table 1. For further conditions ee Mate- 
rials and Methods. 
Time after Gastric acid 
injec tion ou tpu t 
(min) (mval/min) 
Significance 
0 0.01 ± 0.01 
3 0.11 +- 0.01 p < 0.001 
6 0.19 -+ 0.13 p < 0.001 
10 0.13 ± 0.12 p < 0.005 
20 0.05 -+ 0.09 p < 0.1 
30 0.04 + 0.09 p < 0.1 
60 0.02 + 0.02 p < 0.3 
h ighest  p lasma h is tamine  concent ra t ion  reached,  
3.1 ng/ml ,  wou ld  not  have been expected  f rom the 
results o f  h i s tamine  in fus ion  studies (f ig.2),  1o pro- 
duce tachycard ia  or hypotens ion .  
A f ter  in ject ion o f  M ice l lophor  ®, there was no 
change in hear t  rate or b lood  pressure.  
Fo l lowing  th iopentone  in ject ion,  there was a slight 
and short last ing increase in hear t  rate and a sl ight, but  
s igni f icant,  hypotens ion  (f ig.6);  as w i th  propan id id ,  
these changes occur red  before  the max imum increase 
in p lasma h is tamine concent ra t ion .  S t imulat ion  o f  
gastric acid secret ion and the decrease o f  basophi ls  in 
the b lood parallel the increase o f  p lasma h is tamine 
(f ig.6).  There fore ,  and as wi th  propan id id ,  there was 
no corre lat ion  between the changes o f  heart  rate and 
b lood  pressure and the release o f  h i s tamine  into the 
p lasma;  c i rcu latory  changes due to released h is tamine  
were not  expected  f rom a p lasma h is tamine  concen-  
t rat ion o f  3.2 ng/ml.  
4. D ISCUSSION 
Determinat ion  o f  h i s tamine  in b lood  plasma is a 
prerequis i te  for the demonst ra t ion  o f  h i s tamine  re- 
lease in man by anesthet ics .  To date no successful  
methods  ex is ted  for measur ing  such low increases o f  
p lasma h is tamine concent ra t ion .  Fur thermore ,  the 
earlier methods  were not  specif ic for h is tamine 
(Lorenz  et al., 1972). 
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Fig.6. Histamine concentration i whole blood and plasma, 
basophils, gastric acid secretion, blood pressure and heart rate 
after i.v. injection of thiopentone. Mean values _+ S.E.M., 
5 probands were tested after the injection of thiopentone, 
5 mg/kg, i.v., injection time 20 sec. In each person all param- 
eters were studied simultaneously. Heart rate, • •, blood 
pressure •----•. For further conditions see Materials and Meth- 
ods. 
Only the methods of Adam et al. (1957) and 
Graham et al. (1968) produced results in agreement 
with our values (Lorenz et al., 1970a, b, c; Doenicke 
and Lorenz, 1970).The 'histamine values' found by the 
other authors, over a period of more than 30 years 
(for a survey see Lorenz et al., 1972), were either up 
to 100 times too high or were below the limit of 
sensitivity of the method (e.g. below 3 ng/ml). The 
high 'histamine values' were due to substances fluo- 
rescing after condensation with o-phthaldialdehyde 
which were not, or not sufficiently, separated from 
histamine during the purification procedure (Lorenz 
et al., 1970a). The less than satisfactory methods 
used in previous investigations makes necessary revi- 
sion of all results on histamine release in humans 
which are based upon plasma histamine assay. 
Determination of histamine in human blood as a 
measure of histamine release is afflicted with a num- 
ber of problems. As Paton (1957) has already re- 
marked, the determination must include a determina- 
tion of the content of tire corpuscular elements in the 
blood to be assured that their contents have not al- 
tered. Since histamine in human blood is almost ex- 
clusively located in the basophil granutocytes 
(Graham et al., 1955; Lorenz el al., 1972), histamine 
concentration in whole blood is dependent on the 
absolute density of these cells in the blood. The den- 
sity of these cells was altered in approximately 50c,~ 
of cases after propanidid and in ahnost all cases after 
thiopentone. 
In those test persones receiving propanidid and 
with a constant blood basophil content, the histamine 
concentration in whole blood increased to approxi- 
mately 24 ng/ml, whereas the plasma histamine level 
only increased to approximately 3 ng/ml. Thus, the 
increase of histamine in whole blood did not corre- 
spond to the increase in plasma histamine, and above 
all, the histamine was not pharmacologically active, as 
shown by the results of the infusion experiments 
(fig.2). A facultative, short-term uptake in eosinophil 
granulocytes and erythrocytes should be considered 
(Code et al., 1964; Lindell and Viske: 1961: Lorenz 
and Werle, 1971). The eosinophil content increased in 
propanidid and thiopentone narcosis (Lorenz and 
Doenicke, unpublished). However, it is not known if 
the eosinophils tore so much histamine under our ex- 
perimental conditions. 
The big difference between plasma and whole 
blood histamine levels in humans (relationship ap- 
prox. 1 : 100) is the reason why only large increases 
of plasma histamine, as seen in severe incidents 
(Lorenz et al., 1972a), can dependably be measured 
by histamine determination i whole blood, and then 
only when the basophil content remains constant. 
However, since the histamine increase in whole blood 
is not entirely free histamine, the determination of 
this amine in human whole blood as a method for 
determining histamine release by anesthetics and mus- 
cle relaxants (Westgate and van Bergen, 1962: Lorenz 
et al., 1969; Doenicke and Lorenz, 1970), is of lim- 
ited value and should be combined with indirect 
measures uch as gastric secretion, heart or pulse rate 
and blood pressure. 
Indirect methods for the determination of hista- 
mine release are not specific. Therefore, several of the 
following measurements should be included to en- 
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hance specificity of  the assay: determination of  blood 
plessure decrease in peripheral circulation, the so- 
called 'delayed depressor response' (Mclntosh and 
Paton, 1949); tachycardia; hemoconcentrat ion:  gas- 
tric secretion; increase of bronchial resistance upto 
bronchospasm; erythenra, edema (skin tests), etc. The 
prevention of  clinical symptoms by antihistaminics i
also an indirect method of proving histamine release 
although specificity of  antihistaminics is much less 
than is normally assumed (Werle and Lorenz, 1970). 
In the future, all indirect methods should be com- 
bined with a determination of  plasma histamine. The 
value of  such a combined procedure lies above all in 
demonstrat ing the pharmacological nd pathophysio- 
logical effectiveness of histamine released into the 
plasma. The results permit the fol lowing conclusions 
relating to histamine release by propanidid and thio- 
pentone: (1) in normal persons, i.v. injections of  both 
anesthetics release histamine into the plasma, in quan- 
tities sufficient to stimulate gastric acid secretion, but 
not to produce reactions in the circulatory, system; 
increase of heart rate is one of  the most sensitive 
reactions of  the circulatory system to histamine 
(Lecomte,  1956); (2) in normal persons, the changes 
in the circulatory system, e.g. tachycardia nd hypo- 
tension, observed in the first minutes after injection 
of  both anesthetics, cannot be attr ibuted to a release 
of  histamine into the plasma (Lorenz eta l . ,  1972a). 
However, release of  histamilm from the heart cannot 
be excluded as a cause of these reactions and this 
aspect must be separately studied; (3) in persons with 
abnormalit ies relating to histamine storage or catabo- 
lism, as well as in those with an 'allergic diathesis', 
release of large amounts of  histamine by propanidid 
or thiopentone, sufficient to evoke strong reactions 
from the circulatory system cannot be excluded. 
Such incidents with propanidid are described in an- 
other paper (Lorenz et al., 1972a). 
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